Product Information

POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0838 per EA under NDC 72888007500. Its NADAC has been published 176 times since Jul 5, 2023.

FDA first approved this application on Jul 25, 2022. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 10 MEQ TABLET

Potassium Chloride
$0.0838per EA

Strength

750 mg/1

NDC

72888007500

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215725

FDA Approved

7/25/2022

TE Code

AB3

On Market Since

7/25/2022

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 176 times since Jul 5, 2023, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0838 per EA
All-time high$0.1451 (Jul 12, 2023)
All-time low$0.0828 (Sep 23, 2026)
52-week high$0.0943
52-week low$0.0828
Median price$0.0962
Average price$0.1017
Largest weekly change+35.0% (Aug 21, 2024)
Weeks tracked176
Tracking sinceJul 5, 2023

Price History

1W

0.0%

1M

+1.1%

3M

-1.4%

6M

-5.5%

1Y

-5.4%

3Y

-35.2%

5Y

N/A

All

-42.3%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Advagen Pharma Ltd., is $0.0838 per EA (NDC 72888007500), effective Nov 11, 2026.

How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 42.3%. It has been tracked across 176 weekly CMS publications since Jul 5, 2023.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?

Since Jul 5, 2023, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0828 (Sep 23, 2026) to a high of $0.1451 (Jul 12, 2023), with a median of $0.0962 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 10 MEQ TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 10 MEQ TABLET?

POTASSIUM CL ER 10 MEQ TABLET (NDC 72888007500) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.